Risk-prediction tool for identifying hospitalized children with a predisposition for development of venous

A A Sharathkumar1, A Mahajerin, L Heidt

  • 1Ann and Robert H Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. asharathkumar@luriechildrens.org

Insights

A new Peds-Clot clinical Decision Rule (PCDR) identifies children at high risk for venous thromboembolism (VTE). This tool aids in developing evidence-based prevention guidelines for pediatric VTE.

Area of Science:

  • Pediatric Medicine
  • Hematology
  • Clinical Decision Rules

Background:

  • Increasing prevalence of venous thromboembolism (VTE) in pediatric tertiary care settings.
  • Need for standardized criteria to identify high-risk pediatric populations for VTE prevention.

Purpose of the Study:

  • Develop the Peds-Clot clinical Decision Rule (PCDR) to identify children at increased risk of VTE.
  • Establish a risk prediction model for pediatric VTE.

Main Methods:

  • Retrospective case-control study using derivation and validation cohorts.
  • Conditional logistic regression to develop the risk-prediction model.
  • ROC curve analysis to evaluate PCDR performance.

Main Results:

  • Six risk factors identified: bloodstream infection, central venous catheter, ICU/NICU admission, prolonged hospitalization, immobilization, and birth control pill use.
  • PCDR with a score of 3+ identified high-risk children with 70% sensitivity and 80% specificity (AUC 0.852) in the derivation cohort.
  • Validation cohort showed 57% sensitivity and 88% specificity (AUC 0.875).

Conclusions:

  • The PCDR is a promising tool for identifying high-risk hospitalized children for VTE.
  • Clinical utility requires further validation through prospective studies.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...